Clinical trial
Inhaled Albuterol Sulfate For Acute Wheezing Due To Obstructive Airways Disease…
NCT00144846 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00144846 |
|---|---|
| Title | Inhaled Albuterol Sulfate For Acute Wheezing Due To Obstructive Airways Disease In Children |
| Official title | A Randomized, Double-Blind, Parallel-group, Multi-Center Study of Albuterol Sulfate HFA Inhalation Aerosol Delivered Cumulatively With a Valved Holding Chamber and an Attached Facemask in Subjects Between Birth to 23 Months of Age With Acute Wheezing Due to Obstructive Airways Disease |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Asthma |
| Intervention type | Drug |
| Interventions | albuterol sulfate inhalation aerosol |
| Enrollment | 80 |
| Start date | Sep 1, 2004 |
| Primary completion | Feb 1, 2006 |
| Completion | Feb 1, 2006 |
| First posted | Sep 5, 2005 |
| Last update posted | Sep 23, 2016 |
| Countries | Puerto Rico, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: